PROCESSA PHARMACEUTICALS INC (PCSA)

Processa Pharmaceuticals to Participate in the EF Hutton Annual Global Conference

HANOVER, Md., May 06, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage...

Processa Pharmaceuticals Names Dr. Steven Cha Senior Vice President of Clinical Research

Brings extensive experience in all phases of oncology drug development HANOVER, Md., April 30, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc....

Curious about the stocks that are showing activity before the opening bell on Friday?

Which stocks are moving before the opening bell on Friday?

Get insights into the top gainers and losers of Thursday's after-hours session.

Which stocks are moving after the closing bell on Thursday?

Let's take a look at the stocks that are in motion in today's session.

What's going on in today's session

Curious about the most active stocks on Thursday? Find out which stocks are dominating the market action!

Curious about the most active stocks on Thursday? Find out which stocks are dominating the market action!

What's going on in today's session

Intrigued by the market activity in the middle of the day on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.

Thursday's session: gap up and gap down stocks

There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Thursday.

Discover the top movers in Thursday's pre-market session and stay informed about market dynamics.

Get insights into the top gainers and losers of Thursday's pre-market session.

Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference

HANOVER, MD, March 28, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage...

Processa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual Meeting

HANOVER, MD, March 25, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage...

Processa Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference

HANOVER, MD, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage...

Processa Pharmaceuticals to Present at The Winter Wrap-Up MicroCap Rodeo Winter 2024 Virtual Conference

HANOVER, MD, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage...

Processa Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule

HANOVER, MD, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage...

Processa Pharmaceuticals Announces Closing of $7.0 Million Public Offering

HANOVER, MD, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage...

Nasdaq Stocks Above $2 to Watch Now! LVTX, INBS, IKT, PCSA, DYAI

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

It's time to start the trading week with a dive into the biggest pre-market stock movers worth watching on Monday morning!

Processa Pharmaceuticals prices discounted stock and warrants offering to raise $7M

Processa Pharmaceuticals (NASDAQ:PCSA) on Friday priced the public offering of its stock and warrants to raise gross proceeds of up to $7 million.The...

Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering

Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering

HANOVER, Md., Jan. 26, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage...

Why Is Processa Therapeutics (PCSA) Stock Up 90% Today?

Processa Pharmaceuticals successfully completed its safety trial for a key cancer drug. Now, PCSA stock is soaring on the positive implications.